Advanced Clear Cell Renal Cell Carcinoma
18 clinical trials · Condition
◉ Watch Advanced Clear Cell Renal Cell Carcinoma
| Record | Firm | Date |
|---|---|---|
| Sitravatinib and Nivolumab for the Treatment of Metastatic or Advanced Clear Cell Renal Cell Cancer (NCT04904302) | M.D. Anderson Cancer Center | 2022-05-03 |
| Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer (NCT05012371) | M.D. Anderson Cancer Center | 2022-02-16 |
| CBM588 in Combination With Nivolumab and Cabozantinib for the Treatment of Advanced or Metastatic Kidney Cancer (NCT05122546) | City of Hope Medical Center | 2021-11-01 |
Track Advanced Clear Cell Renal Cell Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.